CNR2 and breast cancer: Despite not being significantly enriched in the GO analysis, the present data also show that genes of an activator of the adrenergic pathway and a neurotransmitter receptor (ADRBK2 and GABBR1, respectively), as well as genes of endogenous cannabinoid receptors (CNR2, GPR18) are reduced during the BC to PC transition.